A critical breakthrough in cancer investigation is occurring with the use of nanobodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently disabled in several forms of https://optimusbookmarks.com/story21888143/nanobodies-revive-tumor-suppressor-p53-a-promising-pathway-for-tumor-therapy